Non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is
responsible for the majority of cancer-related deaths worldwide. The management of …
responsible for the majority of cancer-related deaths worldwide. The management of …
Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective
I Houda, C Dickhoff, CA Uyl-de Groot… - The Lancet Regional …, 2024 - thelancet.com
The treatment landscape of resectable early-stage non-small cell lung cancer (NSCLC) is
transforming due to the approval of novel adjuvant and neoadjuvant systemic treatments …
transforming due to the approval of novel adjuvant and neoadjuvant systemic treatments …
Stage III NSCLC treatment options: too many choices
Stage III nonsmall cell lung cancer (NSCLC) represents a wide range of tumour (T1 to T4)
and nodal (N0 to N3) components, requiring variable management and a multidisciplinary …
and nodal (N0 to N3) components, requiring variable management and a multidisciplinary …
[HTML][HTML] Early-stage non-small cell lung cancer: New challenges with immune checkpoint blockers and targeted therapies
P Lavaud, M Bortolot, L Zullo, D O'Reilly, J Naidoo… - Cancers, 2024 - mdpi.com
Simple Summary The current review summarizes the new potential treatment strategies for
patients with early-stage non-small cell lung cancer with immunotherapy and targeted …
patients with early-stage non-small cell lung cancer with immunotherapy and targeted …
[HTML][HTML] An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer
I Houda, I Bahce, C Dickhoff, TE Kroese, SGC Kroeze… - Lung Cancer, 2025 - Elsevier
Abstract Introduction The EORTC-Lung Cancer Group initiated a Delphi consensus process
to establish a consensual definition of resectable stage III non-small cell lung cancer …
to establish a consensual definition of resectable stage III non-small cell lung cancer …
What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?—A Review of Implications for Diagnosis and Treatment
JL Díaz, J Edwards, AL Deleu, N Giaj-Levra… - …, 2024 - pmc.ncbi.nlm.nih.gov
Simple Summary Approximately one third of patients with non-small cell lung cancer are
diagnosed with N2 disease corresponding to stages IIIA–IIIB, according to the current 8th …
diagnosed with N2 disease corresponding to stages IIIA–IIIB, according to the current 8th …
Cancers bronchiques non à petites cellules de stade III: quel abord local optimal?
J De Wolf, C Le Péchoux, T Berghmans - Revue des Maladies …, 2024 - Elsevier
Résumé Le stade III de la classification TNM internationale représente un groupe
hétérogène de maladies dont la prise en charge thérapeutique généralement multimodale …
hétérogène de maladies dont la prise en charge thérapeutique généralement multimodale …
Systematic endoscopic staging of mediastinum in locally advanced NSCLC: a SEISMIC change?
A Botticella, A Levy, C Le Pechoux - The Lancet Respiratory …, 2024 - thelancet.com
Mediastinal lymph node staging of non-metastatic non-small-cell lung cancer (NSCLC) is
crucial as it guides therapy and has a strong prognostic value. Targeted mediastinal tissue …
crucial as it guides therapy and has a strong prognostic value. Targeted mediastinal tissue …
A Podcast on Pre-or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist …
Management of stage II–III non-small cell lung cancer (NSCLC) has been dramatically
revolutionized by studies testing the addition of immunotherapy (IO) to chemotherapy in the …
revolutionized by studies testing the addition of immunotherapy (IO) to chemotherapy in the …
CLICaP Guía CLICaP para el diagnóstico, tratamiento y seguimiento del cáncer de pulmón de células no pequeñas localmente avanzado
El cáncer de pulmón de células no pequeñas (LA-NSCLC) localmente avanzado (estado III)
es una enfermedad heterogénea que representa un desafío por su enorme complejidad …
es una enfermedad heterogénea que representa un desafío por su enorme complejidad …